386967007: Troglitazone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\...

\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Troglitazone

\Peroxisome proliferator-activated gamma receptor agonist\Thiazolidinedione (substance)\Troglitazone

\Drug or medicament (substance)\Peroxisome proliferator-activated receptor agonist\Thiazolidinedione (substance)\Troglitazone

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Sulfur and/or sulfur compound\Sulfur compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Troglitazone

\Organic compound\Organic sulfur compound\Thiazole (substance)\Thiazolidinedione (substance)\Troglitazone

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461145013 Troglitazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481081017 Troglitazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1461145013 Troglitazone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1461145013 Troglitazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481081017 Troglitazone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1481081017 Troglitazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Troglitazone	Is a	Thiazolidinedione (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Troglitazone	Has disposition	Peroxisome proliferator-activated gamma receptor agonist (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing troglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely troglitazone 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)
Troglitazone 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely troglitazone 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely troglitazone 300 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Troglitazone 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Troglitazone 400 mg oral tablet	Has basis of strength substance (attribute)	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Troglitazone 400 mg oral tablet	Has precise active ingredient	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely troglitazone 200 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely troglitazone 300 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Troglitazone-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only troglitazone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only troglitazone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Troglitazone	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets